Your browser doesn't support javascript.
loading
The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective.
Bousquet, Jean; Jutel, Marek; Pfaar, Oliver; Fonseca, Joao A; Agache, Ioana; Czarlewski, Wienczyslawa; Bachert, Claus; Bergmann, Karl Christian; Cruz, Alvaro A; Klimek, Ludger; Kvedariene, Violeta; Larenas-Linnemann, Désirée E; Papadopoulos, Nikolaos G; Patella, Vincenzo; Regateiro, Frederico S; Scichilone, Nicola; Shamji, Mohamed H; Sheikh, Aziz; Valovirta, Erkka; Ventura, Maria-Teresa; Zuberbier, Torsten.
Afiliação
  • Bousquet J; Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany; University Hospital Montpellier, France; MACVIA-France, Montpellier, France. Electronic address: jea
  • Jutel M; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
  • Pfaar O; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Fonseca JA; CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Medida, Lda Porto, Portugal.
  • Agache I; Faculty of Medicine, Transylvania University, Brasov, Romania.
  • Czarlewski W; Medical Consulting Czarlewski, Levallois, France; MASK-air, Montpellier, France.
  • Bachert C; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium; Sun Yat-sen University, International Airway Research Center, First Affiliated Hospital Guangzou, Guangzou, China; Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm, Sweden; Department of
  • Bergmann KC; Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany.
  • Cruz AA; ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil; GARD/WHO Executive Committee, Bahia, Brazil.
  • Klimek L; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Kvedariene V; Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Institute of Clinical Medicine, Clinic of Chest Diseases and Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Larenas-Linnemann DE; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
  • Papadopoulos NG; Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou," University of Athens, Athens, Greece.
  • Patella V; Division of Allergy and Clinical Immunology, Department of Medicine, Agency of Health ASL Salerno, "Santa Maria della Speranza" Hospital, Battipaglia, Salerno, Italy.
  • Regateiro FS; Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Faculty of Medicine, Institute of Immunology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine, ICBR - Coimbra Institute for Clinical and Biomedical Research, CIBB, University of Coimbra, Coimbra, Portug
  • Scichilone N; PROMISE Department, University of Palermo, Palermo, Italy.
  • Shamji MH; Usher Institute, The University of Edinburgh, Edinburgh, United Kingdom.
  • Sheikh A; Immunomodulation and Tolerance Group, Imperial College London, London, United Kingdom; Allergy and Clinical Immunology, Imperial College London, London, United Kingdom.
  • Valovirta E; Department of Lung Diseases and Clinical Immunology, University of Turku, Turku, Finland; Terveystalo Allergy Clinic, Turku, Finland.
  • Ventura MT; University of Bari Medical School, Unit of Geriatric Immunoallergology, Bari, Italy.
  • Zuberbier T; Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Berlin, Germany; Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Berlin, Germany.
J Allergy Clin Immunol Pract ; 9(5): 1805-1812, 2021 05.
Article em En | MEDLINE | ID: mdl-33662672
ABSTRACT
Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis and/or asthma. Many international or national practice guidelines have been produced, but the evidence-based method varies and they do not usually propose care pathways. The present article considers the possible role of mobile health in AIT for allergic rhinitis/asthma. There are no currently available validated biologic biomarkers that can predict AIT success, and mobile health biomarkers have some relevance. In the current article, the following aspects will be discussed patient stratification for AIT, symptom-medication scores for the follow-up of patients, clinical trials, as well as the approach of the European Academy of Allergy and Clinical Immunology.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Telemedicina / Rinite Alérgica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Telemedicina / Rinite Alérgica Idioma: En Ano de publicação: 2021 Tipo de documento: Article